The mode of action of the antitumour agent GP 48,989 in the rat
- 1 May 1979
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer (1965)
- Vol. 15 (5), 755-761
- https://doi.org/10.1016/0014-2964(79)90150-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Radiobiological hypoxia of a transplanted rat tumour and the effect of treatment with cyclophosphamideEuropean Journal of Cancer (1965), 1978
- The gross and cellular response of a rat mammary tumour to single doses of cyclophosphamideEuropean Journal of Cancer (1965), 1978
- Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the ratMolecular and Cellular Endocrinology, 1977
- Antiestrogens in the treatment of breast cancerCancer Treatment Reviews, 1976
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976
- TAMOXIFEN AS AN ANTI-TUMOUR AGENT: OESTROGEN BINDING AS A PREDICTIVE TEST FOR TUMOUR RESPONSEJournal of Endocrinology, 1976
- TAMOXIFEN AS AN ANTI-TUMOUR AGENT: EFFECT ON OESTROGEN BINDINGJournal of Endocrinology, 1976
- Regression of “Hormone-Independent” DMBA-induced Mammary Carcinomas in Response to GP 48989 and its Effect on Hormone ReceptorsOncology, 1976
- Carcinostatic activity of a thiazolidinonylidene-hydrazonothiazolidinone derivative against DMBA-induced mammary carcinomata in female Sprague-Dawley ratsCellular and Molecular Life Sciences, 1973
- An Experimental Method for Comparing Treatments of Intact Malignant Tumours in Animals and its Application to the Use of Oxygen in RadiotherapyBritish Journal of Cancer, 1960